Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
16 participants
OBSERVATIONAL
2015-05-31
2015-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Perioperative Bleeding and Aspirin Use in Spine Surgery
NCT02807441
Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
NCT00748371
Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
NCT00501345
Serum Thromboxane B2 Assay as a Measure of Platelet Production in Healthy Volunteers Taking Aspirin
NCT03424408
The Middle East Dual Anti-platelet Treatment in Acute Transient Ischemic Attack
NCT02144831
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
No aspirin
Subjects who have not taken aspirin or other blood thinners in the previous 10 days
No interventions assigned to this group
Aspirin Daily
Subjects who have taken aspirin daily for the previous 10 or more days
No interventions assigned to this group
New to aspirin
Subjects newly started on aspirin during their visit
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* no history of myocardial infarction, ischemic stroke, or other ischemic event
* have taken aspirin daily over the last 10 days or more
* no history of myocardial infarction, ischemic stroke, or other ischemic event
* have not previously been prescribed aspirin, but have been prescribed aspirin at their present appointment, e.g. a high calcium plaque score on CT
* no history of myocardial infarction, ischemic stroke, or other ischemic event
Exclusion Criteria
* a known bleeding or thrombotic disorder
* have taken aspirin, other NSAIDs, clopidogrel, or an anticoagulant in the previous 10 days
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Emory University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sharon Horesh Bergquist
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharon Bergquist, MD
Role: PRINCIPAL_INVESTIGATOR
Emory University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Emory Clinic
Atlanta, Georgia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00075811
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.